Central 5-HT Neurotransmission modulates weight loss following gastric bypass surgery in obese individuals

Journal of Neuroscience

Volumn 35, Issue 14, 2015, Pages 5884-5889

  Haahr, M E ^a,b   Hansen, D L ^c   Fisher, P M ^a,b   Svarer, C ^a,b   Stenbaek D S ^a,b   Madsen, K ^a,b   Madsen, J ^b   Holst, J J ^b   Baare W F C ^b,c   Hojgaard, L ^b   Almdal, T ^d   Knudsen, G M ^a,b  

^a University of Copenhagen   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c HVIDOVRE HOSPITAL   (Denmark)

^d STENO DIABETES CENTER   (Denmark)

Author keywords

5 HT; 5 HT 2A receptor; 5 HT transporter; Bariatric surgery; Positron emission tomography

Indexed keywords

ALTANSERIN; SEROTONIN; SEROTONIN 2A RECEPTOR; SEROTONIN TRANSPORTER; GLUCAGON LIKE PEPTIDE 1; KETANSERIN; PROTEIN BINDING; SEROTONIN ANTAGONIST;

APPETITE; ARTICLE; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; IMMUNOREACTIVITY; NEUROTRANSMISSION; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SCORING SYSTEM; SEROTONINERGIC SYSTEM; STOMACH SURGERY; UPREGULATION; WEIGHT REDUCTION; ADULT; ANALOGS AND DERIVATIVES; BLOOD; BRAIN; BRAIN MAPPING; CASE CONTROL STUDY; DENMARK; DRUG EFFECTS; FEMALE; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; PROCEDURES; SCINTISCANNING; STOMACH BYPASS; TIME; TREATMENT OUTCOME;

ADULT; BODY MASS INDEX; BRAIN; BRAIN MAPPING; CASE-CONTROL STUDIES; DENMARK; FEMALE; GASTRIC BYPASS; GLUCAGON-LIKE PEPTIDE 1; HUMANS; KETANSERIN; MALE; MIDDLE AGED; OBESITY; PROTEIN BINDING; RECEPTOR, SEROTONIN, 5-HT2A; SEROTONIN ANTAGONISTS; TIME FACTORS; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 84929359443     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.3348-14.2015     Document Type: Article

References (30)

1. Adams KH, Pinborg LH, Svarer C, Hasselbalch SG, Holm S, Haugbøl S, Madsen K, Frøkjaer V, Martiny L, Paulson OB, Knudsen GM (2004) A database of [(18)F]-altanserin binding to 5-HT(2A) receptors in normal volunteers: normative data and relationship to physiological and demographic variables. Neuroimage 21:1105–1113.CrossRef Medline
2. Asarian L (2009) Loss of cholecystokinin and glucagon-like peptide-1 induced satiation in mice lacking serotonin 2C receptors. Am J Physiol Regul Integr Comp Physiol 296:R51–R56.CrossRef Medline
3. Berthoud HR, Zheng H, Shin AC (2012) Food reward in the obese and after weight loss induced by calorie restriction and bariatric surgery. Ann N Y Acad Sci 1264:36–48.CrossRef Medline
4. Cahir M, Ardis T, Reynolds GP, Cooper SJ (2007) Acute and chronic tryptophan depletion differentially regulate central 5-HT1A and 5-HT 2A receptor binding in the rat. Psychopharmacology (Berl) 190:497–506.CrossRef Medline
5. Colquitt JL, Pickett K, Loveman E, GK F (2014) Surgery for weight loss in adults. Cochrane Database Syst Rev 8:CD003641.CrossRef Medline
6. Di Iorio CR, Watkins TJ, Dietrich MS, Cao A, Blackford JU, Rogers B, Ansari MS, Baldwin RM, Li R, Kessler RM, Salomon RM, Benningfield M, Cowan RL (2012) Evidence for chronically altered serotonin function in the cerebral cortex of female 3,4-methylenedioxymethamphetamine polydrug users. Arch Gen Psychiatry 69:399–409.CrossRef Medline
7. Docherty NG, le Roux CW (2014) Improvements in the metabolic milieu following Roux-en-Y gastric bypass and the arrest of diabetic kidney disease. Exp Physiol 99:1146–1153.CrossRef Medline
8. Donovan MH, Tecott LH (2013) Serotonin and the regulation of mammalian energy balance. Front Neurosci 7:36.CrossRef Medline
9. Erritzoe D, Frokjaer VG, Haugbol S, Marner L, Svarer C, Holst K, BaaréWF, Rasmussen PM, Madsen J, Paulson OB, Knudsen GM (2009) Brain serotonin 2A receptor binding: relations to body mass index, tobacco and alcohol use. Neuroimage 46:23–30.CrossRef Medline
10. 2A receptor binding: an in vivo molecular imaging study in humans. J Neurosci 30:3391–3397.
11. Erritzoe D, Frokjaer VG, Haahr MT, Kalbitzer J, Svarer C, Holst KK, Hansen DL, Jernigan TL, Lehel S, Knudsen GM (2010b) Cerebral serotonin transporter binding is inversely related to body mass index. Neuroimage 52:284–289.CrossRef Medline
12. Günther L, Liebscher S, Jähkel M, Oehler J (2008) Effects of chronic citalopram treatment on 5-HT1A and 5-HT2A receptors in group- and isolation-housed mice. Eur J Pharmacol 593:49–61.CrossRef Medline
13. Haahr ME, Rasmussen PM, Madsen K, Marner L, Ratner C, Gillings N, Baaré W, Knudsen GM (2012) Obesity is associated with high serotonin 4 re ceptor availability in the brain reward circuitry. Neuroimage 61:884–888.CrossRef Medline
14. Haahr ME, Fisher PM, Jensen CG, Frokjaer VG, Mahon BM, Madsen K, Baaré WF, Lehel S, Norremolle A, Rabiner EA, Knudsen GM (2014) Central 5-HT4 receptor binding as biomarker of serotonergic tonus in humans: a [11C]SB207145 PET study. Mol Psychiatry 19:427–432.CrossRef Medline
15. Heal DJ, Philpot J, Molyneux SG, Metz A (1985) Intracerebroventricular administration of 5,7-dihydroxytryptamine to mice increases both headtwitch response and the number of cortical 5-HT2 receptors. Neuropharmacology 24:1201–1205.CrossRef Medline
16. Ichise M, Liow JS, Lu JQ, Takano A, Model K, Toyama H, Suhara T, Suzuki K, Innis RB, Carson RE (2003) Linearized reference tissue parametric imaging methods: application to [11C]DASB positron emission tomography studies of the serotonin transporter in human brain. J Cereb Blood Flow Metab 23:1096–1112.CrossRef Medline
17. Lam DD, Garfield AS, Marston OJ, Shaw J, Heisler LK (2010) Brain serotonin system in the coordination of food intake and body weight. Pharmacol Biochem Behav 97:84–91.CrossRef Medline
18. le Roux CW, Welbourn R, Werling M, Osborne A, Kokkinos A, Laurenius A, Lönroth H, Fändriks L, Ghatei MA, Bloom SR, Olbers T (2007) Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass. Ann Surg 246:780–785.CrossRef Medline
19. Licht CL, Marcussen AB, Wegener G, Overstreet DH, Aznar S, Knudsen GM (2009) The brain 5-HT4 receptor binding is down-regulated in the Flinders Sensitive Line depression model and in response to paroxetine administration. J Neurochem 109:1363–1374.CrossRef Medline
20. Meyer JH, Kapur S, Eisfeld B, Brown GM, Houle S, DaSilva J, Wilson AA, Rafi-Tari S, Mayberg HS, Kennedy SH (2001) The effect of paroxetine on 5-HT(2A) receptors in depression: an [(18)F]setoperone PET imaging study. Am J Psychiatry 158:78–85.CrossRef Medline
21. Olesen O, Sibomana M, Keller S, Andersen F, Jensen J, Holm S, Svarer C, Højgaard L (2009) Spatial resolution of the HRRT PET scanner using 3D-OSEM PSF reconstruction. IEEE Nucl Sci Symp Conf Rec 3789–3790.CrossRef Medline
22. Olsen LR, Mortensen EL, Bech P (2006) Mental distress in the Danish general population. Acta Psychiatr Scand 113:477–484.CrossRef Medline
23. Orskov C, Rabenhøj L, Wettergren A, Kofod H, Holst JJ (1994) Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans. Diabetes 43:535–539.CrossRef Medline
24. Pi-Sunyer X (2009) The medical risks of obesity. Postgrad Med 121:21–33.CrossRef Medline
25. Rasmussen H, Ebdrup BH, Oranje B, Pinborg LH, Knudsen GM, Glenthøj B (2014) Neocortical serotonin2A receptor binding predicts quetiapine associated weight gain in antipsychotic-naive first-episode schizophrenia patients. Int J Neuropsychopharmacol 17:1729–1736.CrossRef Medline
26. Ratner C, Ettrup A, Bueter M, Haahr ME, Compan V, le Roux CW, Levin B, Hansen HH, Knudsen GM (2012) Cerebral markers of the serotonergic system in rat models of obesity and after Roux-en-Y gastric bypass. Obesity (Silver Spring) 2:2133–2141.CrossRef Medline
27. Sjostrom L (2008) Bariatric surgery and reduction in morbidity and mortality: experiences from the SOS study. Int J Obes (Lond) 32 [Suppl 7]: S93–S97.CrossRef Medline
28. Spigset O, Mjorndal T (1997) Effect of fluvoxamine on platelet 5-HT2A receptors as studied by [3H]lysergic acid diethylamide ([3H]LSD) binding in healthy volunteers. Psychopharmacology (Berl) 133:39–42.CrossRef Medline
29. Takahashi T (2010) Toward molecular neuroeconomics of obesity. Med Hypotheses 75:393–396.CrossRef Medline
30. Urban NB, Girgis RR, Talbot PS, Kegeles LS, Xu X, Frankle WG, Hart CL, Slifstein M, Abi-Dargham A, Laruelle M (2012) Sustained recreational use of ecstasy is associated with altered pre and postsynaptic markers of serotonin transmission in neocortical areas: a PET study with [(1)(1)C]DASB and [(1)(1)C]MDL 100907. Neuropsychopharmacology 37:1465–1473.CrossRef Medline